AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

Tyman PLC

Board/Management Information Jan 25, 2022

4865_dirs_2022-01-25_d859e658-7799-4d21-b5e1-801d9f487cd0.html

Board/Management Information

Open in Viewer

Opens in native device viewer

National Storage Mechanism | Additional information

RNS Number : 5535Z

Tyman PLC

25 January 2022

TYMAN PLC

("Tyman" or the "Group")

25 January 2022

Director Declaration

In accordance with Listing Rule 9.6.14R, Tyman announces that Jo Hallas, the Group's Chief Executive Officer, will be appointed as a Non-Executive Director of Smith & Nephew plc, the global medical technology business, with effect from 1 February 2022.

Enquiries

Tyman plc

Peter Ho, General Counsel & Company Secretary

020 7976 8000

www.tymanplc.com

Notes to editors

Tyman (TYMN: LSE) is a leading international supplier of engineered fenestration components and access solutions to the construction industry. The company designs and manufactures products that enhance the comfort, sustainability, security, safety and aesthetics of residential homes and commercial buildings. Tyman's portfolio of leading brands serve their markets through three divisions: Tyman North America (AmesburyTruth), Tyman UK & Ireland (ERA) and Tyman International (SchlegelGiesse). Headquartered in London, the Group employs approximately 4,300 people with facilities in 16 countries worldwide. Further information is available at www.tymanplc.com.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

RDNEANFSAAAAEEA

Talk to a Data Expert

Have a question? We'll get back to you promptly.